Prospective Characterization of the Heart, Aorta and Blood Pressure in Turner Syndrome. Association With Aortic Dissection. (TSCORII)

May 23, 2016 updated by: University of Aarhus

Prospective Characterization of the Heart, Aorta and Blood Pressure in Women With Turner Syndrome. Association With Aortic Dissection.

Turner syndrome is a congenital complete or partial lack one of the female sex chromosomes affecting 1 of 2000 live born girls. The syndrome is characterized by an increased prevalence of ischemic heart disease, aortic dilation and dissection, hypertension, stroke and autoimmune diseases in general.

Our study aim is:

  • Using MRI to further characterize and find risk factors leading to aortic dilation.
  • Using MRI to assess the degree of aortic distensibility.
  • Using Computed tomography x-ray scanning of the heart and coronary arteries to characterize the prevalence and degree of ischemic heart disease and coronary anomalies.
  • Using pressure sensitive ultrasound (applanation tonometry) to assess the degree of aortic stiffness when compared to controls using end points as Pulse Wave Velocity, Augmentation Index and Central Pulse Pressure.

Study Overview

Detailed Description

Turner syndrome is a congenital complete or partial lack one of the female sex chromosomes affecting 1 of 2000 live born girls. The syndrome is characterized by an increased prevalence of ischemic heart disease, aortic dilation and dissection, congenital heart defects, hypertension, stroke, ovarian failure, infertility, decreased final height and autoimmune diseases in general

Our study aim is:

  • Using MRI to further characterize and find risk factors leading to aortic dilation.
  • Using MRI to describe aortic dimensions
  • Using MRI to assess the degree of aortic distensibility.
  • Using Computed tomography x-ray scanning of the heart and coronary arteries to characterize the prevalence and degree of ischemic heart disease and coronary anomalies.
  • Using pressure sensitive ultrasound (applanation tonometry) to assess the degree of aortic stiffness when compared to controls using end points as Pulse Wave Velocity, Augmentation Index and Central Pulse Pressure.

Study Type

Observational

Enrollment (Actual)

106

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aarhus, Denmark, 8000
        • Department of Endocrinology and Internal Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Females with Turner Syndrome previously participating in our study number 2001024 are recruited from out-patient clinics.

Controls are healthy volunteers recruited from the general population by advertisement.

Description

Inclusion Criteria with respect to individuals acting as controls:

  • Healthy age matched females

Exclusion Criteria:

  • Contraindications for MRI
  • Contraindications for CT
  • Severe obesity
  • Acute og Chronic disease with known or presumed significance with concern to outcomes of the study
  • Previous or present malignant disease
  • Clinically significant liver disease
  • Mechanic or biological heart valves

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Turner syndrome
Females with Turner syndrome
Control group
age matched females acting as controls

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Aortic dimensions
Time Frame: Once
Aortic dimensions measured by MRI
Once
Agatston score
Time Frame: Once
Coronary CT evaluation of Agatston score
Once
Segment involvement score
Time Frame: Once
Segment involvement score (SIS) calculated as the sum of segments with one or more coronary plaques (score 0-18).
Once
Aortic distensibility
Time Frame: Once
Aortic distensibillity as measured by MRI
Once

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
24 hour blood pressure
Time Frame: 24 hour
24 hour blood pressure
24 hour
Pulse Wave Velocity
Time Frame: Once
Pulse Wave Velocity measured by applanation tonometry.
Once
Augmentation index
Time Frame: Once
Augmentation index measured by applanation tonometry.
Once
Central blood pressure
Time Frame: Once
Central blood pressure measured by applanation tonometry.
Once

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
echocardiography
Time Frame: Once
echocardiography evaluating Mitral and aortic valves, left ventricular hypertrophy, diastolic and systolic function etc..
Once

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Claus H Gravholt, MD, Aarhus University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2013

Primary Completion (ACTUAL)

March 1, 2016

Study Completion (ANTICIPATED)

October 1, 2016

Study Registration Dates

First Submitted

August 30, 2012

First Submitted That Met QC Criteria

August 30, 2012

First Posted (ESTIMATE)

September 3, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

May 24, 2016

Last Update Submitted That Met QC Criteria

May 23, 2016

Last Verified

June 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

3
Subscribe